Under construction – not a live service

Skip to content

Frontlight Research

Institution

Wuhan Union Hospital

Wuhan, ChinahealthcareWebsite

Also known as: Hankow Renji Hospital · Hankow Union Hospital · Union Hospital of Tongji Medical College of Huazhong University of Science and Technology · 武汉协和医院

399running trials
103closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Not yet recruiting
A Study of HS-10382 Versus Investigator-selected TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT07885293· Phase 3· Source
Not yet recruiting
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
NCT07821606· Phase 3· Source
Not yet recruiting
A Prospective, Biomarker-Stratified Phase 2 Study: β-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal Cancer
NCT07847229· Phase 2· Source
Not yet recruiting
TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has Spread
NCT07844187· Phase 1/2· Source
Not yet recruiting
Quad Shot Radiotherapy Combined With Tislelizumab and Platinum-Based Chemotherapy Before Surgery for Stage II-III Non-Small Cell Lung Cancer
NCT07845916· Phase 2· Source
Recruiting
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
NCT07575672· Phase 3· Source
Recruiting
Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
NCT07776080· Phase 2· Source
Not yet recruiting
A Prospective, Multicenter,Single-arm Study of DuoCor 2 Ventricular Assist System for the Treatment of Advanced Biventricular Heart Failure
NCT07757451· Source
Not yet recruiting
Albumin-Bound Paclitaxel (Ⅱ) in Patients With Advanced Breast Cancer
NCT07899047· Source
Not yet recruiting
Union-LC-MPE Cohort:A Multicenter Cohort Study on Diagnosis and Prognosis of Malignant Pleural Effusion in Lung Cance
NCT07882758· Source
Recruiting
QLESP Block for Pain Control in Robotic Partial Nephrectomy
NCT07704970· Source
Recruiting
A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07795346· Phase 3· Source
Recruiting
Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT07687459· Phase 3· Source
Recruiting
A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.
NCT07653685· Phase 1/2· Source
Not yet recruiting
A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension
NCT07833098· Phase 2· Source
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
NCT07796516· Phase 2· Source
Recruiting
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
NCT07678593· Phase 1/2· Source
Not yet recruiting
Rituximab, Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for for Richter Syndrome Transformed From CLL
NCT07831395· Phase 2· Source
Not yet recruiting
Exploring the Efficacy of Ferrous Sulfate/Ferrous Succinate Combined With Serplulimab and SOX Regimen in Neoadjuvant Therapy for Gastric Cancer: A Prospective Cohort Study
NCT07872696· Phase 2· Source
Not yet recruiting
AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum
NCT07829640· Source
Not yet recruiting
A Phase 2 Study of ABSK043 Combined With Osimertinib
NCT07710612· Phase 2· Source
Not yet recruiting
Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients
NCT07742800· Source
Recruiting
SMP-656 for HER2-Positive Advanced Breast Cancer
NCT07726342· Phase 2· Source
Recruiting
A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)
NCT07734311· Phase 3· Source
Not yet recruiting
Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
NCT07741045· Phase 3· Source
Not yet recruiting
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)
NCT07739199· Phase 2/3· Source
Recruiting
IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer
NCT07722494· Phase 3· Source
Recruiting
Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM
NCT07728019· Phase 2· Source
Active, not recruiting
Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT Scans
NCT07739628· Source
Recruiting
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
NCT07518043· Phase 1· Source
Recruiting
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NCT07567625· Source
Not yet recruiting
A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
NCT07677514· Phase 2· Source
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287· Phase 2· Source
Not yet recruiting
Clinical Application Value of Deep Learning-Based "Opportunistic Screening" for Malignant Tumors on Routine Non-Contrast Chest-Abdomen-Pelvis CT
NCT07639567· Source
Enrolling by invitation
Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）
NCT07721441· Source
Not yet recruiting
A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
NCT07550842· Phase 1· Source
Active, not recruiting
The Clinical Application Value of CAIX-Targeted PET Hypoxia Imaging in Malignant Tumors
NCT07890038· Source
Recruiting
Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer
NCT07552402· Source
Recruiting
A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer
NCT07689656· Phase 1/2· Source
Not yet recruiting
Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients
NCT07485764· Phase 4· Source
Not yet recruiting
Treatment of Recurrent/Metastatic Head and Neck Cancer
NCT07601204· Phase 1/2· Source
Not yet recruiting
Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications for Weight Loss
NCT07611552· Source
Not yet recruiting
Blood Exosomal Multi-omics and Lung Radiomics for Predicting Efficacy and Prognosis of Severe Eosinophilic ACOS With Biologics
NCT07602881· Source
Not yet recruiting
Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy
NCT07627464· Phase 2· Source
Recruiting
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
NCT07477587· Phase 1· Source
Recruiting
A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer
NCT07113275· Phase 3· Source
Recruiting
A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer
NCT07462143· Phase 2/3· Source
Recruiting
A Study of YKST02 in Participants With Primary IgA Nephropathy
NCT07498673· Early phase 1· Source
Recruiting
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
NCT07549412· Phase 3· Source
Not yet recruiting
Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus
NCT07512947· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Lung cancer54 recruiting
Colorectal cancer26 recruiting
Childhood cancers16 recruiting
Gastric and esophageal cancer16 recruiting
Lupus (SLE)13 recruiting
Acute lymphoblastic leukaemia12 recruiting
Pancreatic cancer12 recruiting
Head and neck cancer11 recruiting
Liver and biliary tract cancer11 recruiting
Multiple myeloma10 recruiting
Prostate cancer8 recruiting
Chronic lymphocytic leukaemia7 recruiting
Metastatic breast cancer7 recruiting
Rheumatoid arthritis7 recruiting
Sarcoma7 recruiting
Acute myeloid leukemia6 recruiting
Diffuse large B-cell lymphoma6 recruiting
Kidney cancer6 recruiting
Ovarian cancer6 recruiting
Heart failure5 recruiting
Melanoma5 recruiting
Bladder cancer4 recruiting
Cervical cancer4 recruiting
Follicular lymphoma4 recruiting
High blood pressure4 recruiting
Psoriasis4 recruiting
Endometrial cancer3 recruiting
Hepatitis B3 recruiting
Obesity3 recruiting
Systemic sclerosis (scleroderma)3 recruiting
Triple-negative breast cancer3 recruiting
Ulcerative colitis3 recruiting
Asthma2 recruiting
Coronary artery disease2 recruiting
Crohn's disease2 recruiting
Fatty liver disease (MASLD/MASH)2 recruiting
Glioblastoma2 recruiting
Mantle cell lymphoma2 recruiting
Myelodysplastic syndromes2 recruiting
Myeloproliferative neoplasms2 recruiting
Thyroid cancer2 recruiting
Alzheimer disease1 recruiting
Chronic kidney disease1 recruiting
Chronic myeloid leukaemia1 recruiting
COPD1 recruiting
Haemophilia1 recruiting
Idiopathic pulmonary fibrosis1 recruiting
IgA nephropathy1 recruiting
Macular degeneration1 recruiting
Myasthenia gravis1 recruiting
Neuroendocrine tumours1 recruiting
Osteoporosis1 recruiting
Parkinson disease1 recruiting
Primary biliary cholangitis1 recruiting
Psoriatic arthritis1 recruiting
Pulmonary arterial hypertension1 recruiting
Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

Withdrawn
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT07583030· Early phase 1· Source
Completed
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
NCT07060885· Phase 3· Source
Completed
The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors
NCT07651020· Source
Withdrawn
A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases
NCT06869278· Phase 1· Source
Completed
A First-in-Human Study of ¹⁷⁷Lu-HX02 in Sarcoma Patients
NCT07847268· Source
Completed
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
NCT06653556· Early phase 1· Source
Completed
End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance Tomography-guided PEEP Titration Methods in Patients With Intra-abdominal Hypertension Combined With Acute Respiratory Distress Syndrome: a Randomized Crossover Controlled Study
NCT06697717· Source
Completed
Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets
NCT06610890· Phase 1· Source
Completed
A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors
NCT06549816· Phase 1· Source
Completed
DuoCor Ventricular Assist System Early Feasibility Study
NCT06878508· Source
Completed
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment
NCT06380153· Phase 1· Source
Completed
[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy
NCT06982053· Source
Completed
A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis
NCT06280716· Phase 3· Source
Completed
A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma
NCT05046314· Phase 2· Source
Completed
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
NCT06214741· Phase 3· Source
Completed
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
NCT06173037· Phase 2· Source
Completed
A Clinical Study of JS005 in Patients With Ankylosing Spondylitis
NCT06250062· Phase 2· Source
Completed
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
NCT06066528· Phase 3· Source
Completed
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
NCT06088043· Phase 3· Source
Completed
A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
NCT06029127· Phase 2· Source
Completed
Different Doses of Colchicine on hsCRP
NCT06078904· Phase 4· Source
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06049017· Phase 2· Source
Completed
Donor Circadian Rhythm and Its Correlation With Prognosis After Heart Transplantation
NCT07301788· Source
Completed
Evaluating Different Doses of Orelabrutinib in MCL
NCT05978739· Phase 2· Source
Completed
Effect of APRV vs. LTV on Right Heart Function in ARDS Patients: a Single-center Randomized Controlled Study
NCT05922631· Source
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
NCT05646862· Phase 3· Source
Completed
A Study of DS-7011a in Patients With Systemic Lupus Erythematosus
NCT05638802· Phase 1/2· Source
Completed
A Psychosocial Dyadic Programme for Patients With Heart Failure and Their Family Caregivers
NCT05864469· Source
Completed
A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
NCT05704738· Phase 3· Source
Completed
Study of Telitacicept in Generalized Myasthenia Gravis
NCT05737160· Phase 3· Source
Completed
A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A
NCT05707351· Phase 3· Source
Completed
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
NCT05593575· Phase 2· Source
Completed
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT05687032· Phase 4· Source
Completed
A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)
NCT05724199· Phase 3· Source
Completed
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
NCT06266143· Phase 1/2· Source
Terminated
A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma
NCT05590377· Phase 1/2· Source
Completed
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
NCT05559580· Phase 2· Source
Terminated
Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
NCT05611853· Phase 1/2· Source
Completed
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
NCT05507203· Phase 3· Source
Completed
A Phase I Study to Evaluate the Safety and Tolerability of JL15003 Injection in Patients With Recurrent Glioblastoma
NCT07497373· Phase 1· Source
Completed
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
NCT05508867· Phase 2· Source
Completed
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
NCT05321069· Phase 3· Source
Terminated
Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
NCT05461794· Phase 2· Source
Withdrawn
A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL
NCT05365100· Phase 1/2· Source
Completed
A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma
NCT05420324· Phase 2· Source
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
NCT05398445· Phase 3· Source
Completed
Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)
NCT05298423· Phase 3· Source
Completed
Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma With Ociperlimab (BGB-A1217) in Combination With Tislelizumab (BGB-A317) or Rituximab
NCT05267054· Phase 1/2· Source
Terminated
A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL
NCT05265975· Phase 1/2· Source
Completed
Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
NCT05218499· Phase 2/3· Source

Trial sites

Conditions

Diseases this institution publishes on or runs trials for.

Lung cancer138 works · 105 trials
Liver and biliary tract cancer96 works · 17 trials
Colorectal cancer72 works · 37 trials
Gastric and esophageal cancer49 works · 28 trials
Ovarian cancer29 works · 15 trials
Pancreatic cancer29 works · 18 trials
Glioblastoma27 works · 4 trials
Cervical cancer23 works · 8 trials
Kidney cancer22 works · 12 trials
Osteoporosis21 works · 4 trials
Diffuse large B-cell lymphoma14 works · 20 trials
Endometrial cancer14 works · 6 trials
Acute lymphoblastic leukaemia14 works · 16 trials
Thyroid cancer10 works · 4 trials
Chronic myeloid leukaemia10 works · 1 trials

Institution data: ROR 0371fqr87 (CC0-1.0)Updated 10 Nov 2026

Report an error